EUVIMEDEUVIMED entdecken
Open Access

dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa

Qing Wang iD, Xiaoshu Xu iD, Siyu Chen, Rui Lu, Liang Li, Chien-Hui Lo iD, Zhiquan Liu, Ke Ning iD, Tingting Li, Tia J Kowal iD, Biao Wang iD, Mary E Hartnett und 3 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.adn7540 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Qing Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94304, USA. Hauptthemen laut MEDLINE: Retinitis Pigmentosa, Disease Models, Animal, Cyclic Nucleotide Phosphodiesterases, Type 6, Genetic Therapy. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NEI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinitis pigmentosa (RP) is characterized by degeneration of rod and cone photoreceptors that progresses to irreversible blindness. Now, there are no mutation-agnostic approaches to treat RP. Here, we utilized a single adeno-associated virus (AAV)–based CRISPR activation system to activate phosphodiesterase 6B (Pde6b) to mitigate the severe degeneration in Pde6a nmf363 mice. We demonstrate that transcriptional activation of Pde6b can rescue the loss of Pde6a , with preservation of retinal structure, restoration of electroretinography responses, and improvement of visual function as assessed by optokinetic response and looming-induced escape behaviors. These findings demonstrate the therapeutic potential of a dCasMINI-mediated activation strategy that provides a mutation-independent treatment for retinal degeneration. This study offers a promising therapeutic approach for RP and potentially other forms of genetic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinitis PigmentosaDisease Models, AnimalCyclic Nucleotide Phosphodiesterases, Type 6Genetic TherapyDependovirusAnimalsMiceElectroretinographyRetinal DegenerationCRISPR-Cas SystemsHumansRetinal Rod Photoreceptor CellsEye ProteinsRetinal Cone Photoreceptor Cells

Substanzen

Cyclic Nucleotide Phosphodiesterases, Type 6Pde6b protein, mousePde6a protein, mouseEye Proteins

Autor:innen und Institutionen

  • Byers Eye Institute, Department of Ophthalmology, Stanford University, Palo Alto, CA 94304, USA.
  • Department of Bioengineering, Stanford University, Stanford, CA 94305, USA.
  • Department of Molecular and Cellular Physiology, Stanford University, Stanford, CA 94305, USA.
  • Department of Ophthalmology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.
  • Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA.
  • Chan Zuckerberg Biohub-San Francisco, San Francisco, CA 94158, USA.

ORCID-Profile: Qing Wang, Xiaoshu Xu, Chien-Hui Lo, Ke Ning, Tia J Kowal, Biao Wang, Sui Wang, Yang Sun

Förderung

  • NEI NIH HHS

Zitieren

APA

Wang, Q., Xu, X., Chen, S., Lu, R., Li, L., Lo, C. H., Liu, Z., Ning, K., Li, T., Kowal, T. J., Wang, B., Hartnett, M. E., Wang, S., Qi, L. S., & Sun, Y. (2024). dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa. Science Advances. https://doi.org/10.1126/sciadv.adn7540

Vancouver

Wang Q, Xu X, Chen S, Lu R, Li L, Lo CH, et al. dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa. Science Advances. 2024. doi:10.1126/sciadv.adn7540

BibTeX
@article{Wang2024,
  author = {Wang, Qing and Xu, Xiaoshu and Chen, Siyu and Lu, Rui and Li, Liang and Lo, Chien-Hui and Liu, Zhiquan and Ning, Ke and Li, Tingting and Kowal, Tia J and Wang, Biao and Hartnett, Mary E and Wang, Sui and Qi, Lei S and Sun, Yang},
  title = {dCasMINI-mediated therapy rescues photoreceptors degeneration in a mouse model of retinitis pigmentosa},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.adn7540}
}
Kostenlos starten →